ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
3 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
732
|
150K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
UKTrader54
|
189 |
42K |
1 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
189
|
42K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
2 |
18/04/21 |
18/04/21 |
ASX - By Stock
|
732
|
150K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 3G - Long Term Incentive Options Issued to CEO
|
|
UKTrader54
|
7 |
3.1K |
1 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
7
|
3.1K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Completes Dosing in Phase 1 Clinical Study of AMP945
|
|
UKTrader54
|
9 |
2.6K |
0 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
9
|
2.6K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp secures firm commitments to raise $5.5 million
|
|
UKTrader54
|
66 |
26K |
5 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
66
|
26K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp secures firm commitments to raise $5.5 million
|
|
UKTrader54
|
66 |
26K |
3 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
66
|
26K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp secures firm commitments to raise $5.5 million
|
|
UKTrader54
|
66 |
26K |
5 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
66
|
26K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Successful Completion of Dosing in First Patient Cohort
|
|
UKTrader54
|
50 |
20K |
5 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
50
|
20K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
29 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
732
|
150K
|
29
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp secures firm commitments to raise $5.5 million
|
|
UKTrader54
|
66 |
26K |
11 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
66
|
26K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
UKTrader54
|
130 |
46K |
1 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
130
|
46K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
UKTrader54
|
130 |
46K |
1 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
130
|
46K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
6 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
732
|
150K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
UKTrader54
|
130 |
46K |
2 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
130
|
46K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Receives $750k R&D Tax Incentive Refund
|
|
UKTrader54
|
7 |
1.8K |
18 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
7
|
1.8K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: TGA clearance achieved for wearable
|
|
UKTrader54
|
23 |
9.8K |
1 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
23
|
9.8K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Annual General Meeting Date
|
|
UKTrader54
|
1 |
733 |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
1
|
733
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX
|
|
UKTrader54
|
265 |
142K |
9 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
265
|
142K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
4 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
732
|
150K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
3 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
732
|
150K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
10 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
732
|
150K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
UKTrader54
|
21K |
7.6M |
9 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
21K
|
7.6M
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
UKTrader54
|
39 |
10K |
16 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
39
|
10K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?
|
|
UKTrader54
|
114 |
24K |
6 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
114
|
24K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
UKTrader54
|
1.4K |
559K |
0 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
1.4K
|
559K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Thirty reasons to buy ATX (Amplia Therapeutics)
|
|
UKTrader54
|
20 |
10K |
1 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
20
|
10K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update March 2021
|
|
UKTrader54
|
519 |
163K |
6 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
519
|
163K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on Phase IIb Clinical Trial of Monepantel in Pet Dogs
|
|
UKTrader54
|
56 |
12K |
4 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
56
|
12K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Major Shareholder Loan for $5 Million
|
|
UKTrader54
|
52 |
15K |
7 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
52
|
15K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on Phase IIb Clinical Trial of Monepantel in Pet Dogs
|
|
UKTrader54
|
56 |
12K |
9 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
56
|
12K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
what is it going to take to see .30 again ?
|
|
UKTrader54
|
50 |
18K |
5 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
50
|
18K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PharmAust is on track for Oral CV-19 treatment?
|
|
UKTrader54
|
59 |
14K |
10 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
59
|
14K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
|
|
UKTrader54
|
106 |
31K |
1 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
106
|
31K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
|
|
UKTrader54
|
106 |
31K |
5 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
106
|
31K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
UKTrader54
|
1.4K |
319K |
12 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
1.4K
|
319K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Licensing Agreement to Develop Waste to Fuels Technology
|
|
UKTrader54
|
36 |
9.3K |
22 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
36
|
9.3K
|
22
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Positive Results Evaluation of EXO-NET in Pancreatic Cancer
|
|
UKTrader54
|
146 |
52K |
0 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
146
|
52K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Change in substantial holding
|
|
UKTrader54
|
185 |
55K |
10 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
185
|
55K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Positive Results Evaluation of EXO-NET in Pancreatic Cancer
|
|
UKTrader54
|
146 |
52K |
2 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
146
|
52K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
CLTX-CAR T is a game changer
|
|
UKTrader54
|
83 |
39K |
3 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
83
|
39K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?
|
|
UKTrader54
|
114 |
24K |
15 |
13/03/21 |
13/03/21 |
ASX - By Stock
|
114
|
24K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?
|
|
UKTrader54
|
114 |
24K |
5 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
114
|
24K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Current Covid Restrictions Holland
|
|
UKTrader54
|
1 |
424 |
7 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
1
|
424
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Time to show your cards.
|
|
UKTrader54
|
26 |
7.3K |
4 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
26
|
7.3K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
UKTrader54
|
114 |
32K |
26 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
114
|
32K
|
26
|
|
ASX - By Stock
|
1AI |
Re:
Ann: CEO's presentation to AGM and market update
|
|
UKTrader54
|
10 |
4.7K |
1 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
10
|
4.7K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?
|
|
UKTrader54
|
114 |
24K |
11 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
114
|
24K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?
|
|
UKTrader54
|
114 |
24K |
12 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
114
|
24K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
Ann: CLARITY 2.0 Study Progresses In Patients With COVID-19
|
|
UKTrader54
|
73 |
26K |
5 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
73
|
26K
|
5
|
|